Suppr超能文献

相似文献

1
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773.
2
Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):125-38. doi: 10.1016/j.bpg.2015.01.001. Epub 2015 Jan 20.
3
Chemoprevention in Barrett's oesophagus.
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):151-65. doi: 10.1016/j.bpg.2014.12.003. Epub 2014 Dec 29.
4
Malignant Barrett's oesophagus.
Eur J Cancer Prev. 1993 Jan;2(1):47-52. doi: 10.1097/00008469-199301000-00008.
6
Barrett's oesophagus: Current controversies.
World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051.
7
[Revision needed of follow-up policy for Barrett's esophagus].
Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):150-4.
8
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
Gut. 2014 Jan;63(1):191-202. doi: 10.1136/gutjnl-2013-305490. Epub 2013 Oct 3.
9
Prognostic value of p53 in Barrett's oesophagus.
Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81-4.
10
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
Nutr Res Rev. 2010 Dec;23(2):230-46. doi: 10.1017/S0954422410000132. Epub 2010 Jul 13.

引用本文的文献

1
Infectious Agents and Esophageal Cancer: A Comprehensive Review.
Cancers (Basel). 2025 Apr 7;17(7):1248. doi: 10.3390/cancers17071248.
5
The Role of Long Noncoding RNAs (lncRNAs) in Esophageal Cancer Therapy Resistance and Metastasis.
Biomedicines. 2024 Mar 15;12(3):660. doi: 10.3390/biomedicines12030660.
6
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
9
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned.
Diagnostics (Basel). 2023 Aug 12;13(16):2664. doi: 10.3390/diagnostics13162664.
10
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma : Insights from a Large Neoadjuvant Endocrine Therapy Cohort.
Cancer Res Commun. 2022 Dec 7;2(12):1579-1589. doi: 10.1158/2767-9764.CRC-22-0263. eCollection 2022 Dec.

本文引用的文献

1
2
When mutants gain new powers: news from the mutant p53 field.
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.
3
Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.
Gut. 2009 Nov;58(11):1451-9. doi: 10.1136/gut.2009.180281. Epub 2009 Aug 2.
4
Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.
Histopathology. 2009 Jun;54(7):814-9. doi: 10.1111/j.1365-2559.2009.03316.x.
5
DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.
Am J Gastroenterol. 2009 Sep;104(9):2153-60. doi: 10.1038/ajg.2009.300. Epub 2009 Jul 7.
6
Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2079-89. doi: 10.1158/1055-9965.EPI-09-0265. Epub 2009 Jun 30.
7
Medication usage and the risk of neoplasia in patients with Barrett's esophagus.
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304. doi: 10.1016/j.cgh.2009.06.001. Epub 2009 Jun 10.
8
9
Radiofrequency ablation in Barrett's esophagus with dysplasia.
N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验